Report of the 3rd and 4th Mystery of Reactive Oxygen Species Conference

Main Article Content

Shihori Tanabe , Danielle Beaton, Vinita Chauhan, Ian Choi, Judy Choi, Laure-Alix Clerbaux, Lucia Coppola, Antonio Fernandez Dumont, Maranda Esterhuizen, Julija Filipovska, Rex FitzGerald, Ellen Fritsche, Natalia Garcia-Reyero, Anna Goralczyk, Elizabeth Huliganga, Young-Jun Kim, Jördis Klose, Cinzia La Rocca, Brigitte Landesmann, Angela Mally, Sivakumar Murugadoss, Elma Omeragic, Gladys Ouédraogo, Jorge Matias Pereira, Baki Sadi, Alexandra Schaffert, You Song, Iva Sovadinova, Tobias Stöger, Knut Erik Tollefsen, Clemens Wittwehr, Carole Yauk
[show affiliations]

Article Details

How to Cite
Tanabe, S. (2023) “Report of the 3rd and 4th Mystery of Reactive Oxygen Species Conference”, ALTEX - Alternatives to animal experimentation, 40(4), pp. 689–693. doi: 10.14573/altex.2307041.
Meeting Reports

Carusi, A., Filipovska, J., Wittwehr, C. et al. (2023). CIAO: aA living experiment in interdisciplinary large-scale collaboration facilitated by the adverse outcome pathway framework. Front Public Health 11, 1212544. doi:10.3389/fpubh.2023.1212544

Clerbaux, L.-A., Albertini, M. C., Amigó, N. et al. (2022a). Factors modulating COVID-19: A mechanistic understanding based on the adverse outcome pathway framework. J Clin Med 11, 4464. doi:10.3390/jcm11154464

Clerbaux, L.-A., Fillipovska, J., Muñoz, A. et al. (2022b). Mechanisms leading to gut dysbiosis in COVID-19: Current evidence and uncertainties based on adverse outcome pathways. J Clin Med 11, 5400. doi:10.3390/jcm11185400

Clerbaux, L.-A., Mayasich, S. A., Muñoz, A. et al. (2022c). Gut as an alternative entry route for SARS-CoV-2: Current evidence and uncertainties of productive enteric infection in COVID-19. J Clin Med 11, 5691. doi:10.3390/jcm11195691

Clerbaux, L. A., Amigó, N., Amorim, M. J. et al. (2022d). COVID-19 through adverse outcome pathways: Building networks to better understand the disease – 3rd CIAO AOP design workshop. ALTEX 39, 322-335. doi:10.14573/altex.2112161

Hogberg, H. T., Lam, A., Ohayon, E. et al. (2022). The adverse outcome pathway framework applied to neurological symptoms of COVID-19. Cells 11, 3411. doi:10.3390/cells11213411

Ives, C., Campia, I., Wang, R. L. et al. (2017). Creating a structured AOP knowledgebase via ontology-based annotations. Appl In Vitro Toxicol 3, 298-311. doi:10.1089/aivt.2017.0017

Nymark, P., Sachana, M., Leite, S. B. et al. (2021). Systematic organization of COVID-19 data supported by the adverse outcome pathway framework. Front Public Health 9, 638605. doi:10.3389/fpubh.2021.638605

Shahbaz, M. A., De Bernardi, F., Alatalo, A. et al. (2022). Mechanistic understanding of the olfactory neuroepithelium involvement leading to short-term anosmia in COVID-19 using the adverse outcome pathway framework. Cells 11, 3027. doi:10.3390/cells11193027

Tanabe, S., Beaton, D., Chauhan, V. et al. (2022a). Report of the 1st and 2nd mystery of reactive oxygen species conferences. ALTEX 39, 336-338. doi:10.14573/altex.2203011

Tanabe, S., O’Brien, J., Tollefsen, K. E. et al., (2022b). Reactive oxygen species in the adverse outcome pathway framework: Toward creation of harmonized consensus key events. Front Toxicol 4, 887135. doi:10.3389/ftox.2022.887135

Vinken, M. (2021). Covid-19 and the liver: An adverse outcome pathway perspective. Toxicology 455, 152765. doi:10.1016/j.tox.2021.152765

Wittwehr, C., Amorim, M. J., Clerbaux, L. A. et al. (2021). Understanding covid-19 through adverse outcome pathways – 2nd CIAO AOP design workshop. ALTEX 38, 351-357. doi:10.14573/altex.2102221

Wittwehr, C., Chang, X., Bisson, W. et al., (2023). Methods2AOP: An International Collaboration to Integrate Assay Annotations into the AOP Key Event Descriptions.


Most read articles by the same author(s)

1 2 3 4 > >>